<?xml version="1.0" encoding="UTF-8"?>
<p id="Par39">The disease is typically confirmed by reverse-transcription polymerase chain reaction (RT-PCR) reverse Real-Time PCR assay (rRT-PCR), which can be carried out using a variety of clinical specimens, including Bronchoalveolar lavage fluid, fibro bronchoscope brush biopsies, sputum, nasal swabs, pharyngeal swabs, feces, or blood [
 <xref ref-type="bibr" rid="CR9">9</xref>]. But it has been reported that the sensitivity of RT-PCR might not be enough for the diagnosis of the disease. So the Computed tomography (CT), as a noninvasive imaging approach, can detect certain characteristic manifestations in the lung associated with COVID-19 [
 <xref ref-type="bibr" rid="CR7">7</xref>, 
 <xref ref-type="bibr" rid="CR10">10</xref>].
</p>
